Results 11 to 20 of about 49,096 (199)

Hipertensión arterial pulmonar secundaria a infección por virus de inmunodeficiencia humana: a propósito de un caso

Revista Methodo
La hipertensión pulmonar es un trastorno que puede involucrar múltiples condiciones clínicas. Dentro de su clasificación, la hipertensión arterial pulmonar se asocia a la infección por el virus de inmunodeficiencia humana, entidad con baja incidencia ...
Di Martino M L, Cabrera F B, Mezzacapo F, Gutierrez Magaldi I M, Barcudi R J, Camporro F A   +5 more
doaj   +2 more sources

Hipertensión arterial pulmonar y la eritrocitosis precede a la enfermedad pulmonar obstructiva crónica en fumadores residentes de grandes alturas

ARS Medica, 2022
Introducción: la eritrocitosis excesiva afecta a los habitantes de grandes alturas como La Paz, Bolivia, a 3600 msnm. El objetivo del presente trabajo es determinar la existencia de hipertensión arterial pulmonar en pacientes fumadores con eritrocitosis
Ariel Oliver Velarde Zegada, Gustavo Vásquez Durán, Mercedes Villena Cabrera   +2 more
doaj   +2 more sources

[Clinical course of COVID-19 in pulmonary arterial hypertension patients]. [PDF]

Rev Esp Cardiol, 2020
Nuche J, Pérez-Olivares C, Segura de la Cal T, Jiménez López-Guarch C, Arribas Ynsaurriaga F, Escribano Subías P.   +5 more
europepmc   +3 more sources

[Pulmonary arterial hypertension and COVID-19]. [PDF]

Med Intensiva (Engl Ed), 2020
Avellanas Chavala ML.
europepmc   +2 more sources

Physiological and pathophysiological roles of the KCNK3 potassium channel in the pulmonary circulation and the heart

The Journal of Physiology, Volume 601, Issue 17, Page 3717-3737, 1 September 2023., 2023
Abstract figure legend Potassium channel subfamily K member 3 (KCNK3) is functionally expressed in pulmonary vascular and cardiac cells. KCNK3 loss of function and expression leads to pulmonary arterial hypertension (PAH) and right ventricular failure (RVF).
Anaïs Saint‐Martin Willer, Joana Santos‐Gomes, Rui Adão, Carmen Brás‐Silva, Mélanie Eyries, Francisco Pérez‐Vizcaino, Véronique Capuano, David Montani, Fabrice Antigny   +8 more
wiley   +1 more source

Design and fabrication of a microfluidic system with embedded circular channels for rotary cell culture

Biotechnology Journal, Volume 18, Issue 7, July 2023., 2023
Graphical Abstract and Lay Summary The development of functional blood vessels today is a fundamental pillar in the evaluation of new therapies and diagnostic agents to treat pulmonary hypertension. In this study, a rotary incubation system has been used to ensure the homogeneous adhesion of endothelial cells in the walls of a tubular device fabricated
Oihane Mitxelena‐Iribarren, Xabier Bujanda, Laura Zabalza, Janire Alkorta, Aitziber Lopez‐Elorza, Raquel Gracia, Damien Dupin, Sergio Arana, Jesús Ruiz‐Cabello, Maite Mujika   +9 more
wiley   +1 more source

Characterization of the Population With Intermediate-Risk Status in Pulmonary Arterial Hypertension: Patients in a Latin American Country: The CAPRI Registry. [PDF]

Pulm Circ
ABSTRACT Pulmonary arterial hypertension (PAH) in intermediate‐risk patients poses a challenge for clinicians, particularly in determining the optimal timing for escalating pharmacological treatment. We conducted a multicenter cross‐sectional study that analyzed data from the Colombian Pulmonary Hypertension Network (HAPredCO) on patients diagnosed ...
Conde-Camacho R, Orozco-Levi M, Londoño A, Gómez-Palau R, Tuta-Quintero E, Naranjo A, Díaz K, De Luque J, Goldfeder S, Giraldo-Cadavid LF, Guerrero MC, Red Colombiana de Hipertensión Pulmonar – HAPredCo..   +11 more
europepmc   +2 more sources

The impact of COVID‐19 pandemic on pulmonary hypertension: What have we learned?

Pulmonary Circulation, Volume 12, Issue 4, October 2022., 2022
Abstract The coronavirus 2019 disease (COVID‐19) pandemic threatened the Spanish health‐care system. Patients with demanding conditions such as precapillary pulmonary hypertension (PH) faced a potentially severe infection, while their usual access to medical care was restricted.
Williams Hinojosa, María José Cristo‐Ropero, Alejandro Cruz‐Utrilla, Teresa Segura de la Cal, Francisco López‐Medrano, Rafael Salguero‐Bodes, Carmen Pérez‐Olivares, Begoña Navarro, Nuria Ochoa, Fernando Arribas Ynsurriaga, Pilar Escribano‐Subias   +10 more
wiley   +1 more source

Differences in health policies for drug availability in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension across Latin America

Pulmonary Circulation, Volume 12, Issue 1, January 2022., 2022
Abstract Treatment for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in Latin America differs between countries, with regard to disease etiology, health insurance coverage, and drug availability. A group of experts from Latin America, met to share regional experiences and propose possible lines of collaboration.
Mauricio Orozco‐Levi, Jorge Cáneva, Caio Fernandes, Ricardo Restrepo‐Jaramillo, Nayeli Zayas, Rafael Conde, Mirta Diez, Carlos Jardim, Manuel C. Pacheco Gallego, Luciano Melatini, Héctor Valdéz, Tomás Pulido   +11 more
wiley   +1 more source

Parámetros ecocardiográficos de severidad en hipertensión arterial pulmonar

Revista médica, 2023
La Hipertensión Arterial Pulmonar se define por cateterismo cardiaco como la Presión media de la Arteria Pulmonar(PAPm) mayor 20 mmHg en reposo, con presión capilar pulmonar < 15 mmHg y resistencias pulmonares ≥ 2 unidadesWood (Humbert et al., 2022).
Luis Morales R
semanticscholar   +1 more source